Prasol Chemicals Limited IPO
What the filing actually says
Our read of the offer document and the exchange data — not the issuer's summary of itself
The filing raises real questions — 2 of 6 signals read negative
- Steady revenue growthRevenue compounding at 18.6%
- Conservative balance sheetDebt/equity of 0.25×
- Majority offer for sale84.0% of the issue is existing shareholders selling down
- Proceeds mostly repay debt₹60 Cr of the ₹80 Cr raised repays borrowings — deleveraging rather than expansion
- Minimal related-party dealingsRelated-party transactions are only 0.4% of revenue
- 1 high-severity disclosure84% of the offer is an Offer for Sale, so most proceeds go to selling shareholders, not the company.
Every line above is arithmetic on a figure shown elsewhere on this page - no model, no opinion. It describes the quality of the offering as disclosed, and is pulled toward neutral to reflect how much the document leaves unsaid. It is not a prediction of the listing price, and it is not advice to apply.
Dates
The issuer's tentative timetable — a date passing is not confirmation the step completed
- Opens08 Sept 2026
- Closes10 Sept 2026
- Allotment11 Sept 2026
- Listing16 Sept 2026
The offering
Terms, structure and who is selling
What the money is for
Stated use of the net proceeds
- 01Repayment and/or pre-payment of certain borrowings, in full or part, availed by our Company₹60 Cr
- 02General corporate purposesnot stated
Objects with no stated amount — typically general corporate purposes — are funded from whatever remains, so the quantified figures do not sum to the whole issue.
Financials
Restated figures as reported in the offer document, ₹ crore
| Period | Revenue | EBITDA | PAT | Net worth | Debt |
|---|---|---|---|---|---|
| 2024 | 876.565 | — | — | — | — |
| 2025 | 1,012.494 | — | — | — | — |
| 2026 | 1,232.593 | — | — | — | — |
How the issuer compares
The listed companies the offer document itself names as comparable.
| Company | EPS | P/E | NAV | RoNW |
|---|---|---|---|---|
| Aarti Industries Limited | 11.55 | 46.75 | 164.27 | 7.04% |
| Atul Limited | 230.25 | 28.04 | 2136.46 | 10.95% |
| Excel Industries Limited | 60.19 | 17.12 | 1354.74 | 4.44% |
| Laxmi Organic Industries Limited | 2.86 | 59.74 | 71.66 | 4.00% |
| Prasol Chemicals Limitedthis issue | 14.33 | — | 77.33 | 18.53% |
| Privi Specialty Chemicals Limited | 81.08 | 42.67 | 368.79 | 21.99% |
| Vinati Organics Limited | 42.80 | 30.95 | 304.99 | 14.03% |
| Yasho Industries Limited | 20.95 | 206.68 | 368.18 | 5.69% |
Blank cells are figures the offer document does not publish. An unlisted issuer has no market price, so it has no price-based multiple until it lists — which is exactly why the comparison is against companies that already trade. The peer set is the issuer's own selection, so read it as the flattering-est comparison available rather than a neutral one.
Risks worth reading
Ranked by our severity assessment, not by the order the prospectus prints them
84% of the offer is an Offer for Sale, so most proceeds go to selling shareholders, not the company.
mediumOur business is dependent on our manufacturing facilities and we are subject to certain related risks, including the breakdown or failure of equipment, power supply or processes, performance below expected levels of output, efficiency, labour disputes, strikes, environmental issues, lock-outs, non-a
mediumUnplanned slowdowns, unscheduled shutdowns or prolonged disruptions in our manufacturing operations or under-utilization of our manufacturing capacities could have an adverse effect on our business, results of operations, cash flows and financial condition.
mediumIn the event that we are forced to shut down our manufacturing facility for a significant period of time, it would have a material adverse effect on our earnings, our results of operations and our financial condition as a whole.
mediumOur manufacturing facilities are subject to regulatory risks, including instances where the Maharashtra Pollution Control Board (MPCB) has directed us to shut down manufacturing activities, such as the closure of the Khopoli Manufacturing Facility for approximately 55 days in 2018 and the Cease oper
Positives the filing discloses (1)
Debt-to-equity of 0.25x.
What happened to comparable issues
The last 8 issues to list with a recorded opening price, most comparable first
Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.
About Prasol Chemicals Limited
Prasol Chemicals Limited is a specialty chemicals manufacturer incorporated in 1992. The company is involved in the manufacture of acetone-based, phosphorous-based and other specialty chemicals involving complex chemistries. Its product portfolio comprises over 150 specialty chemical products, including 21 acetone-based chemicals, 53 phosphorous-based chemicals and 76 other specialty products such as surfactants, performance additives, ethers, esters, polymers and acids. These products are used across performance chemicals, paints, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care industries. The company manufactures products such as diacetone alcohol, isophorone, hexylene glycol, meta xylenol, phosphorous pentasulphide, phosphorous pentoxide, dithio-phosphates, polyphosphoric acid, DETC and phosphate esters. As of July 15, 2026, the company had over 1,600 customers and exported its products to 69 countries. The company also states that it was the only manufacturer of isophorone in India during the period covered by the CARE Report.
Offer documents
The primary sources everything above is drawn from
Common questions
What is the minimum investment in the Prasol Chemicals Limited IPO?
One lot is 22 shares, so a retail application at the ₹676 cut-off price blocks ₹14,872. Retail applications are capped at ₹2,00,000; above that you bid in the HNI category, where allotment is proportionate rather than by lottery.
When is the Prasol Chemicals Limited IPO allotment date?
Allotment is scheduled for 2026-09-11, with listing on 2026-09-16. These dates are the issuer's tentative timetable — a date passing is not confirmation that the step completed. Allotment status is published by the registrar, KARVY.
Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.